(Q34451423)

2 August 2017

title

The absorption and metabolism of a standard oral dose of levodopa in patients with Parkinsonism (English)

1 reference

2 August 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

5

Marsden CD

1 reference

2 August 2017

Bergmann S

1

1 reference

2 August 2017

Curzon G

2

1 reference

2 August 2017

Friedel J

3

1 reference

2 August 2017

Godwin-Austen RB

4

1 reference

2 August 2017

Parkes JD

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 1974

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

417-424

1 reference

The pathogenesis of Parkinson's disease: a new hypothesis.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

L-dopa treatment failure: explanation and correction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

L-dopa-induced accumulation of 3-O-methyldopa in brain and heart

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

Effects of L-dopa on norepinephrine metabolism in the brain

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

"On-Off" Phenomena Related to High Plasma Levodopa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

Long-term side-effects of levodopa.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402477

Plasma DOPA response to levodopa administration in man: Effects of a peripheral decarboxylase inhibitor

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22454921

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22454921

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Parkinsonism treated with 3-O-methyldopa

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22454921

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1974.TB00280.X

1 reference

2 August 2017

1 reference

2 August 2017

1 reference